News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Entrepreneur Seamus Mulligan Cashes In $86 Million Of Jazz Pharmaceuticals plc (JAZZ) To Fund New Venture


3/21/2014 8:19:52 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Entrepreneur Séamus Mulligan has cashed in shares worth $86 million (€62 million) in Jazz Pharmaceuticals which will entirely be used to fund a new business called Adapt Pharma. Mr Mulligan has co-founded Dublin-based Adapt with fellow serial pharmaceutical entrepreneurs David Brabazon and Eunan Maguire. All three men previously worked with Elan Pharmaceuticals before they successfully co-founded a company called Azur Pharma, which merged with Jazz Pharmaceuticals in 2012.

Help employers find you! Check out all the jobs and post your resume.

Read at Irish Times


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES